Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
What it found
We found no results in the registry or in papers.
This trial finished 6 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- generation of 'omic markers of disease progression
What it measured
Main measures
Generation of 'omic markers of disease progression
5 years
Who could take part
Progressive MS · 18 to 100
Inclusion Criteria: * Enrolled in the MURDOCK Study Horizon 1.5 (Pro00011196) * Enrolled in the Multiple Sclerosis Cohort (Pro00023791) * Diagnosed with Primary Progressive Multiple Sclerosis * At least 18 years of age Exclusion Criteria: * Participants not willing to participate or sign informed consent
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The goal of this study is to enroll 100 participants with Primary Progressive Multiple Sclerosis (PPMS) that have joined the MURDOCK Study Horizon 1.5 (Duke IRB Pro00011196) and the Multiple Sclerosis cohort (Duke IRB Pro00023791). All 100 participants will complete a biannual collection of a follow up questionnaire and blood/urine collection for a period of 5 years.
Loading reviews and guidelines…
History
Started
Jan 2013
Main results due
Sept 2020
Finished
Sept 2020
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error